How I do it – Inzidentalom der Nebenniere

Hinweis

Die Beiträge in der Rubrik „How I do it“ sind als Anregung und Orientierungshilfe zu verstehen. Es bleibt jeder/jedem Kollegin/Kollegen überlassen, von diesem Schema abzuweichen, sofern man sich mit der Indikationsfrage befasst hat und sachliche Gründe für ein alternatives Vorgehen sprechen.

• Literatur

• 1 Johnson PT, Horton KM, Megibow AJ. et al. Common incidental findings on MDCT: survey of radiologist recommendations for patient management. J Am Coll Radiol 2011; 8: 762 doi:10.1016/j.jacr.2011.05.012
• 2 Mayo-Smith WW, Boland GW, Noto RB. et al. State-of-the-art adrenal imaging. Radiographics 2001; 21: 995 doi:10.1148/radiographics.21.4.g01jl21995
• 3 NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 2002; 19: 1-25
• 4 Choyke PL. ACR Appropriateness Criteria on incidentally discovered adrenal mass. J Am Coll Radiol 2006; 3: 498 doi:10.1016/j.jacr.2006.02.031
• 5 Grumbach MM, Biller BMK, Braunstein GD. et al. Management of the clinically inapparent adrenal mass (“incidentaloma”). Ann Intern Med 2003; 138: 424 doi:10.7326/0003-4819-138-5-200303040-00013
• 6 Mansmann G, Lau J, Balk E. et al. The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 2004; 25: 309 doi:10.1210/er.2002-0031
• 7 Young jr. WF. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 2007; 356: 601 doi:10.1056/NEJMcp065470
• 8 Mayo-Smith WW, Song JH, Boland GL. et al. Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2017; 14: 1038 doi:10.1016/j.jacr.2017.05.001
• 9 Grossman A, Koren R, Tirosh A. et al. Prevalence and clinical characteristics of adrenal incidentalomas in potential kidney donors. Endocr Res 2016; 41: 98 doi:10.3109/07435800.2015.1076455
• 10 Schieda N, Siegelman ES. Update on CT and MRI of Adrenal Nodules. AJR Am J Roentgenol 2017; 208: 1206 doi:10.2214/AJR.16.17758
• 11 Blake MA, Cronin CG, Boland GW. Adrenal imaging. AJR Am J Roentgenol 2010; 194: 1450 doi:10.2214/AJR.10.4547
• 12 Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 2008; 190: 1163 doi:10.2214/AJR.07.2799
• 13 Mayo-Smith WW, Lee MJ, McNicholas MM. et al. Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures. AJR Am J Roentgenol 1995; 165: 91 doi:10.2214/ajr.165.1.7785642
• 14 Katz RL, Patel S, Mackay B. et al. Fine needle aspiration cytology of the adrenal gland. Acta Cytol 1984; 28: 269
• 15 Pagani JJ. Normal adrenal glands in small cell lung carcinoma: CT-guided biopsy. AJR Am J Roentgenol 1983; 140: 949 doi:10.2214/ajr.140.5.949
• 16 Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010; 102: 605 doi:10.1093/jnci/djq099
• 17 Kassirer JP. Our stubborn quest for diagnostic certainty. A cause of excessive testing. N Engl J Med 1989; 320: 1489 doi:10.1056/NEJM198906013202211
• 18 Pandharipande PV, Herts BR, Gore RM. et al. Rethinking Normal: Benefits and Risks of Not Reporting Harmless Incidental Findings. J Am Coll Radiol 2016; 13: 764 doi:10.1016/j.jacr.2016.03.017
• 19 Kalra MK, Sodickson AD, Mayo-Smith WW. CT Radiation: Key Concepts for Gentle and Wise Use. Radiographics 2015; 35: 1706 doi:10.1148/rg.2015150118
• 20 Mayo-Smith WW, Hara AK, Mahesh M. et al. How I do it: managing radiation dose in CT. Radiology 2014; 273: 657 doi:10.1148/radiol.14132328
• 21 Boland GW, Lee MJ, Gazelle GS. et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998; 171: 201 doi:10.2214/ajr.171.1.9648789
• 22 Sangwaiya MJ, Boland GWL, Cronin CG. et al. Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT-10-minute delayed imaging protocol revisited in a large patient cohort. Radiology 2010; 256: 504 doi:10.1148/radiol.10091386
• 23 Korobkin M, Brodeur FJ, Francis IR. et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 1998; 170: 747 doi:10.2214/ajr.170.3.9490968
• 24 Krestin GP, Steinbrich W, Friedmann G. Adrenal masses: evaluation with fast gradient-echo MR imaging and Gd-DTPA-enhanced dynamic studies. Radiology 1989; 171: 675 doi:10.1148/radiology.171.3.2717737
• 25 Seo JM, Park BK, Park SY. et al. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 2014; 202: 1043 doi:10.2214/AJR.13.11389
• 26 Caoili EM, Korobkin M, Francis IR. et al. Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 2000; 175: 1411 doi:10.2214/ajr.175.5.1751411
• 27 Caoili EM, Korobkin M, Francis IR. et al. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222: 629 doi:10.1148/radiol.2223010766
• 28 Kumagae Y, Fukukura Y, Takumi K. et al. Distinguishing adrenal adenomas from non-adenomas on dynamic enhanced CT: a comparison of 5 and 10 min delays after intravenous contrast medium injection. Clin Radiol 2013; 68: 696 doi:10.1016/j.crad.2013.01.016
• 29 Blake MA, Kalra MK, Sweeney AT. et al. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 2006; 238: 578 doi:10.1148/radiol.2382041514
• 30 Pena CS, Boland GW, Hahn PF. et al. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 2000; 217: 798 doi:10.1148/radiology.217.3.r00dc29798
• 31 Kamiyama T, Fukukura Y, Yoneyama T. et al. Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol. Radiology 2009; 250: 474 doi:10.1148/radiol.2502080302
• 32 Korobkin M, Francis IR. Imaging of adrenal masses. Urol Clin North Am 1997; 24: 603 doi:10.1016/s0094-0143(05)70404-3
• 33 Szolar DH, Kammerhuber FH. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 1998; 207: 369 doi:10.1148/radiology.207.2.9577483
• 34 Terzolo M, Stigliano A, Chiodini I. et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol 2011; 164: 851 doi:10.1530/EJE-10-1147
• 35 Israel GM, Bosniak MA. How I do it: evaluating renal masses. Radiology 2005; 236: 441 doi:10.1148/radiol.2362040218
• 36 Herts BR, Silverman SG, Hindman NM. et al. Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol 2018; 15: 264 doi:10.1016/j.jacr.2017.04.028
• 37 Johnson PT, Horton KM, Fishman EK. Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics 2009; 29: 1319 doi:10.1148/rg.295095026
• 38 Wortman JR, Bunch PM, Fulwadhva UP. et al. Dual-Energy CT of Incidental Findings in the Abdomen: Can We Reduce the Need for Follow-Up Imaging?. AJR Am J Roentgenol 2016; 207: W58-W68 doi:10.2214/AJR.16.16087
• 39 Ho LM, Marin D, Neville AM. et al. Characterization of adrenal nodules with dual-energy CT: can virtual unenhanced attenuation values replace true unenhanced attenuation values?. AJR Am J Roentgenol 2012; 198: 840 doi:10.2214/AJR.11.7316
• 40 Glazer DI, Maturen KE, Kaza RK. et al. Adrenal Incidentaloma triage with single-source (fast-kilovoltage switch) dual-energy CT. AJR Am J Roentgenol 2014; 203: 329 doi:10.2214/AJR.13.11811
• 41 Morgan DE, Weber AC, Lockhart ME. et al. Differentiation of high lipid content from low lipid content adrenal lesions using single-source rapid kilovolt (peak)-switching dual-energy multidetector CT. J Comput Assist Tomogr 2013; 37: 937 doi:10.1097/RCT.0b013e3182aaf996
• 42 Kim YK, Park BK, Kim CK. et al. Adenoma characterization: adrenal protocol with dual-energy CT. Radiology 2013; 267: 155 doi:10.1148/radiol.12112735
• 43 Wortman JR, Sodickson AD. Pearls, Pitfalls, and Problems in Dual-Energy Computed Tomography Imaging of the Body. Radiol Clin North Am 2018; 56: 625 doi:10.1016/j.rcl.2018.03.007
• 44 Kaza RK, Raff EA, Davenport MS. et al. Variability of CT Attenuation Measurements in Virtual Unenhanced Images Generated Using Multimaterial Decomposition from Fast Kilovoltage-switching Dual-energy CT. Acad Radiol 2017; 24: 365 doi:10.1016/j.acra.2016.09.002
• 45 Adam SZ, Nikolaidis P, Horowitz JM. et al. Chemical Shift MR Imaging of the Adrenal Gland: Principles, Pitfalls, and Applications. Radiographics 2016; 36: 414 doi:10.1148/rg.2016150139
• 46 Siegelman ES. Adrenal MRI: techniques and clinical applications. J Magn Reson Imaging 2012; 36: 272 doi:10.1002/jmri.23601
• 47 Degenhart C. Tumoren der Nebennieren, Prinzipien der Bildgebung und Differenzialdiagnosen. Radiologe 2014; 54: 998 doi:10.1007/s00117-014-2690-y
• 48 Haider MA, Ghai S, Jhaveri K. et al. Chemical shift MR imaging of hyperattenuating (10 HU) adrenal masses: does it still have a role?. Radiology 2004; 231: 711 doi:10.1148/radiol.2313030676
• 49 Seo JM, Park BK, Park SY. et al. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT. AJR Am J Roentgenol 2014; 202: 1043 doi:10.2214/AJR.13.11389
• 50 Glazer DI, Mayo-Smith WW. Management of incidental adrenal masses: an update. Abdom Radiol (NY) 2019; DOI: 10.1007/s00261-019-02149-2.
• 51 Boland GWL, Dwamena BA, Jagtiani Sangwaiya M. et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 2011; 259: 117-126 doi:10.1148/radiol.11100569
• 52 Hahner S, Sundin A. Metomidate-based imaging of adrenal masses. Horm Cancer 2011; 2: 348 doi:10.1007/s12672-011-0093-3
• 53 Ilias I, Sahdev A, Reznek RH. et al. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 2007; 14: 587 doi:10.1677/ERC-07-0045
• 54 Trojan J, Schwarz W, Sarrazin C. et al. Role of ultrasonography in the detection of small adrenal masses. Ultraschall Med 2002; 23: 96 doi:10.1055/s-2002-25190
• 55 Fujiyoshi F, Nakajo M, Fukukura Y. et al. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 2003; 180: 1649 doi:10.2214/ajr.180.6.1801649
• 56 Korobkin M, Giordano TJ, Brodeur FJ. et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology 1996; 200: 743 doi:10.1148/radiology.200.3.8756925
• 57 Lee MJ, Hahn PF, Papanicolaou N. et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179: 415 doi:10.1148/radiology.179.2.2014283
• 58 Ream JM, Gaing B, Mussi TC. et al. Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed-phase imaging at 1.5 T and 3 T. AJR Am J Roentgenol 2015; 204: 536 doi:10.2214/AJR.14.12941
• 59 Boland GWL, Blake MA, Hahn PF. et al. Incidental adrenal lesions: principles, techniques, and algorithms for imaging characterization. Radiology 2008; 249: 756 doi:10.1148/radiol.2493070976
• 60 Pantalone KM, Gopan T, Remer EM. et al. Change in adrenal mass size as a predictor of a malignant tumor. Endocr Pract 2010; 16: 577 doi:10.4158/EP09351.OR
• 61 Song JH, Chaudhry FS, Mayo-Smith WW. The incidental indeterminate adrenal mass on CT (10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR Am J Roentgenol 2007; 189: 1119 doi:10.2214/AJR.07.2167
• 62 Boland GWL, Blake MA, Holalkere NS. et al. PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 2009; 192: 956 doi:10.2214/AJR.08.1431
• 63 Song JH, Grand DJ, Beland MD. et al. Morphologic features of 211 adrenal masses at initial contrast-enhanced CT: can we differentiate benign from malignant lesions using imaging features alone?. AJR Am J Roentgenol 2013; 201: 1248 doi:10.2214/AJR.12.10302
• 64 Patel J, Davenport MS, Cohan RH. et al. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma?. AJR Am J Roentgenol 2013; 201: 122 doi:10.2214/AJR.12.9620
• 65 Schieda N, Krishna S, McInnes MDF. et al. Utility of MRI to Differentiate Clear Cell Renal Cell Carcinoma Adrenal Metastases From Adrenal Adenomas. AJR Am J Roentgenol 2017; 209: W152-W159 doi:10.2214/AJR.16.17649
• 66 Sydow BD, Rosen MA, Siegelman ES. Intracellular lipid within metastatic hepatocellular carcinoma of the adrenal gland: a potential diagnostic pitfall of chemical shift imaging of the adrenal gland. AJR Am J Roentgenol 2006; 187: W550-1 doi:10.2214/AJR.06.0506
• 67 Dong A, Cui Y, Wang Y. et al. (18)F-FDG PET/CT of adrenal lesions. AJR Am J Roentgenol 2014; 203: 245 doi:10.2214/AJR.13.11793